Jagsonpal Pharma Files BRSR for FY26

Jagsonpal Pharmaceuticals Ltd has submitted its Business Responsibility and Sustainability Report (BRSR) for the financial year ended March 31, 2026. The report, forming part of the Annual Report, details the company's corporate identity, operations, employee data, and market reach. The company is primarily engaged in the marketing and distribution of pharmaceutical formulations, with exports contributing a small percentage of its turnover. As of the reporting date, the company has a subsidiary named Aequitas Healthcare Pvt Ltd.